Multi-Omics Approaches in Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (10 April 2022) | Viewed by 34037
Special Issue Editor
Interests: genomics; proteomics; biomarkers; system biology; precision therapy
Special Issue Information
Dear Colleagues,
With the development of personalized medicine, antitumor therapy, including tyrosine kinase and immune checkpoint inhibitors, is now based on individual patient profiles. While a single type of omics study can provide a significant amount of information at a specific level (e.g., genomics for the mutational landscapes of cancer patients), the complexity of cancer–host interactions can only be addressed by combining complementary approaches (such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics) to provide a complete picture of tumor abnormalities. Therefore, multi-omics-based subtype analysis encompassing proteome and phosphoproteome profiling of cancerous tissues, in conjunction with genomic analysis, offers the promise of better elucidating the intertwining of cancer signaling and key metabolic pathways. This combinatorial approach leads to the possible discovery of more effective diagnostic tools and new therapeutic opportunities for patients.
The purpose of this Special Issue is to explore the expanding diversity of mechanisms that regulate oncodriver activation and signaling in human cancer that may provide new opportunities for personalized anti-cancer therapies. This Special Issue welcomes both reviews as well as original research articles by 30 June 2021.
Prof. Dr. Jérôme Solassol
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genomics
- proteomics
- biomarkers
- system biology
- precision therapy
- kinase inhibitors